key: cord-0850052-h5lgh4vr
authors: Arora, Shweta; Singh, Prithvi; Dohare, Ravins; Jha, Rishabh; Ali Syed, Mansoor
title: Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19)
date: 2020-08-15
journal: Gene
DOI: 10.1016/j.gene.2020.145057
sha: f13b9ec7852b4153d6bfae053ee1a016687d6da6
doc_id: 850052
cord_uid: h5lgh4vr

Abstract COVID-19 is a lurking calamitous disease caused by an unusual virus, SARS-CoV-2, causing massive deaths worldwide. Nonetheless, explicit therapeutic drugs or clinically approved vaccines are not available for COVID-19. Thus, a comprehensive research is crucially needed to decode the pathogenic tools, plausible drug targets, committed to the development of efficient therapy. Host-pathogen interactions via host cellular components is an emerging field of research in this respect. miRNAs have been established as vital players in host-virus interactions. Moreover, viruses have the capability to manoeuvre the host miRNA networks according to their own obligations. Besides protein coding mRNAs, noncoding RNAs might also be targeted in infected cells and viruses can exploit the host miRNA network via ceRNA effect. We have predicted a ceRNA network involving one miRNA (miR-124-3p), one mRNA (Ddx58), one lncRNA (Gm26917) and two circRNAs (Ppp1r10, C330019G07RiK) in SARS-CoV infected cells. We have identified 4 DEGs-Isg15, Ddx58, Oasl1, Usp18 by analyzing a mRNA GEO dataset. There is no notable induction of IFNs and IFN-induced ACE2, significant receptor responsible for S-protein binding mediated viral entry. Pathway enrichment and GO analysis conceded the enrichment of pathways associated with interferon signalling and antiviral-mechanism by IFN-stimulated genes. Further, we have identified 3 noncoding RNAs, playing as potential ceRNAs to the genes associated with immune mechanisms. This integrative analysis has identified noncoding RNAs and their plausible targets, which could effectively enhance the understanding of molecular mechanisms associated with viral infection. However, validation of these targets is further corroborated to determine their therapeutic efficacy.

Coronaviruses form a varied group of single-stranded positive-sense RNA viruses, known to infect an extensive range of vertebrate hosts, and causing moderate illnesses of the respiratory tract such as the common cold. An emergence of three, profoundly pathogenic human coronaviruses, from zoonotic viruses has been observed in the former three decades. These include -the Middle East Respiratory-Syndrome-related Coronavirus (MERS-CoV), circulating in both camels and humans. It was not so virulent in case of camels but highly pathogenic in humans, affecting ~ 2,500 people around the world, with a case-fatality rate of ~ 36%; Severe Acute Respiratory-Syndrome-related Coronavirus (SARS-CoV-1), influencing a global population of approximately 8,000 people and a case-fatality rate of around 10% in [2002] [2003] ; and the recent severe acute respiratory-syndrome-related coronavirus (SARS-CoV-2), causing Coronavirus Disease-2019 , the global mortality rate of which needs to be determined (Blanco-Melo et al., 2020; Hasan et al., 2014) . Viruses displaying nucleotide identity to SARS were identified in hosts such as palm civets, raccoon dogs in 2002-2003 SARS epidemic. Later on, highly conserved viral strains existing in horseshoe bats were found to bind and infect human cells. Therefore, these SARS-like coronaviruses, using bats, civets and human ACE2 (Angiotensin 1 converting enzyme 2) receptors do not have clear zoonotic origins but are strongly suggestive of further outbreaks in human populations. An infection with these tremendously pathogenic coronaviruses may lead to severe lung disorders such as acute respiratory distress syndrome (ARDS) and acute lung injury (ALI), usually resulting in loss of lung function and even death (Cascella et al., 2020) .

COVID-19, the disease caused by SARS-CoV-2 is a matter of considerable interest and can be calamitous. According to the latest and largest data set of the new coronavirus outbreak, released by The Chinese Centre for Disease Control and Prevention (https://www.cdc.gov/), the severity of the disease varies among patients, but preponderant cases were expressed mild, with the majority of them having cold-like symptoms to mild Pneumonia. Around 14% of entrenched cases were found to be severe, associated with serious Pneumonia and shortness of breath. 5% of patients were extremely critical exhibiting septic shock, respiratory failure, and multi-organ failure, and approximately 2.3% of them culminated in death. An analysis of the data from 45,000 accustomed cases from China has suggested that elderly people and persons with pre-existent illnesses are more prone to foster relentless forms of (https://www.the-scientist.com/news-opinion/why-some-covid-19-cases-are-worse-than others-67160). Thus, this specific template of enhancing severity with age is different from other viral outbreaks, prominently, the 1918 Flu pandemic, manifesting high rate of mortality in young children and people between 20 and 40 years of age. Nonetheless, it is commodiously persistent with records of MERS and SARS coronavirus outbreaks. Moreover, it is also ambiguous that the new coronavirus is more fatal than the other forms that are frequently found circulating among people in winters and frequently causes common cold (Gralinski and Baric, 2015; Harenberg and Favaloro, 2020) .

Although there is adequate information about the mortality of the clinical disease, but knowledge about its pathobiology is restricted. Despite this, no data displaying the detailed cellular responses to the virus, but data from previous studies with SARS-CoV can be used to hypothesize the plausible course of events taking place during infection. Previous studies have suggested that cells that are probably infected, determine that COVID-19 can be divided into three different phases, each comparable to the different clinical stage of the disease. Phase 1 corresponds to the asymptomatic state i.e. initial 1-2 days of infection, wherein the sniffed SARS-CoV-2 virus binds to epithelial cells of nasal cavity via S-protein mediated binding and initiates replication. Consequently, replicase poly-proteins are translated by the positive strand of RNA genome which is then further cleaved by 16 nsps (nonstructural proteins encoded by the single-stranded virus). ACE2 is the cardinal receptor for both SARS-CoV and SARS-CoV-2 (Hofmann et al., 2004; Wrapp et al., 2020) . In vitro data has suggested that ciliated cells are the primarily infected cells in the conducting airways, but the expression of ACE2 on these cells is limited. Moreover, there is no cell type preference in the conducting airways which is suggestive of viral propagation only, with very little immune response during this phase. Nasal swabs can be used to detect the virus at this stage (Mason, 2020) . Phase 2 conforms the migration of virus in the upper airways along with conducting airways, leading to the stimulation of a sturdy immune response within next few days of infection. The disease COVID-19 is clinically manifested at this point. The levels of cytokines can be used to determine the extent of innate immune response generated. Β and λ interferons secreted by viral infected epithelial cells, CXCL10 secreted by alveolar type II cells have been reported to be effective disease markers in SARS. Determination of the host innate immune response might be suggestive of the subsequent course of the disease. However, the disease is mild and confined to upper respiratory tract and conducting airways in around 80% of the infected persons. Furthermore, approximately 20% of the patient's progress towards phase 3 wherein virus infects alveolar type II cells, the gas exchange units of lungs. The virus propagates and releases a large number of viral particles in these cells leading to apoptosis of the infected cells.

Thus, it acts as a self-replicating pulmonary toxin by releasing new viral particles that further infect adjacent type II cells. In this way, most of the type II cells of lung will be ravaged, triggering the secondary pathways for epithelial regeneration. This would result in diffused alveolar damage with fibrin rich hyaline membranes and the presence of multinucleated giant cells, finally culminating in abrupt stimulation of wound healing processes, leading to the development of pulmonary fibrosis (Gu and Korteweg, 2007; Qian et al., 2013; Wu and McGoogan, 2020; Xu et al., 2020) . Disease resumption would require epithelial regeneration and persuasive innate and acquired immune responses. It has been reported that SARS-CoV proliferates inside Type II cells leading to their apoptotic cell death followed by a release of large number of viral particles (Qian et al., 2013) . As a result, the released viral particles infect adjacent type II cells, propagate inside them and release more viral particles, after cell death.

Thus, it acts as a self-replicating pulmonary toxin, which upon infection, promotes its own replication and death of the infected cell, finally resulting in the release of more and more viral particles. Consequently, most of the type II cells will be lost and secondary pathways for epithelial regeneration would be triggered. Moreover, it would result in the generation of few multinucleated giant cells and diffused alveolar damage with fibrin rich hyaline membranes.

In addition, Type I cells would also not be synthesised as Type II cells are the precursor cells for Type I cells. Such altered wound healing responses would result in more profound Scaring and Fibrosis than that occurs in ARDS (Gu and Korteweg, 2007; Xu et al., 2020, p. 19; Yee et al., 2017) . Elderly people are at higher risk due to their curtailed immune response and diminished mucociliary clearance and repairing capability (Cascella et al., 2020; Harenberg and Favaloro, 2020) .

Although the occurrence of a viral disease is very challenging and requires prompt responses, but specific drugs are not available for several viral diseases including coronaviruses. Hence, the study of host and pathogen interactions will definitely play a significant role in the development of antiviral therapeutics. However, conventional therapeutics is based on the use of neutralizing antibodies, but more recently, genomic medicine has come up with the discovery of microRNAs (miRNAs), long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs), based on gene silencing. miRNAs are small noncoding RNAs (~ 19-26 nts) that regulate posttranscriptional gene expression by binding to the complementary sites on the 3'UTR of target mRNA and causing either its degradation or inhibits its translation. It has been well cited that several plants, animals, and viruses encode these noncoding RNAs that regulate numerous important aspects of cellular processes involving proliferation, development, differentiation, apoptosis, metabolism, and tumorigenesis. Transcription Factors (TFs) are proteins which assist in regulation of gene transcription by binding to DNA-binding domains in the promoter region of target genes (Lee and Young, 2000) . The regulation of both TFs and miRNAs is strongly interconnected as they both share same regulatory logics (Hobert, 2008) .

Besides, they act in a largely combinatorial manner, cooperatively regulating the same target genes. As TFs and miRNAs may also mutually regulate each other, feed-forward loops (FFLs) comprising genes, TFs, and miRNAs thus exist . FFLs can be broadly differentiated into three types according to the master regulator: TF-FFL, miRNA-FFL, and composite FFL (Sun et al., 2012) . Moreover, the regulatory network analysis revealed that FFLs comprise over-represented network motifs in the mammalian regulatory network (Shalgi et al., 2007; Tsang et al., 2007) . miRNAs encoded by viruses are unique in a way that they regulate the gene expression of both the virus and their host. lncRNAs (noncoding RNAs of >200nts) and circRNAs bind to miRNAs competitively via miRNA response elements and act as competing endogenous RNAs (ceRNAs). Thus, ceRNAs regulate the expression of miRNAs targeting specific mRNAs, thereby acting as a sponge for miRNAs. Some of the contemporary studies have demonstrated the plausible role of miRNAs as an antiviral therapeutic tool in case of HSV, Dengue, HIV-1, Hepatitis-C virus (HCV) and Influenza (Barbu et al., 2020; Ghosal et al., 2014; Miao et al., 2019) . Therefore, identification of lncRNA,/circRNA-help in constructing a ceRNA network, which may provide novel and effective targets for the development of innovative therapeutic strategies. Our study has identified a few budding targets of SARS-CoV-2 and their interrelations with miRNA and lncRNAs, which could be effective tools in building antiviral therapy against the deadly SARS-CoV-2.

An exhaustive searching in NCBI-Gene Expression Omnibus (GEO) (Clough and Barrett, 2016) was performed for extracting the SARS-CoV associated mRNA expression dataset. 

The Search Tool for the Retrieval of Interacting Genes (STRING, https://string-db.org/) v11.0 (Szklarczyk et al., 2019) web-based tool was used to analyze the interaction of these DEGs in the form of Protein-Protein Interaction (PPI) network and visualized via Cytoscape v3.8.0 (Shannon et al., 2003) . Confidence score was considered as a highly significant > . threshold in STRING for the construction of PPI network. We also analyzed the PPI network topological properties via Network Analyzer plugin available in Cytoscape. Moreover, the Molecular Complex Detection (MCODE) plugin available in Cytoscape was used to analyze the PPI network and to identify the highly correlated gene clusters/modules. The parameters set as the threshold for network scoring and cluster finding were as follows: "Degree cutoff ", "node score cutoff ", "k-score ", and "max. depth " (Pan et al., 2018) .

Pathway enrichment analysis of genes belonging to the highest scoring cluster was performed to filter out the hub genes followed by their GO term enrichment analysis. Pathway enrichment analysis of the highest-scoring cluster genes was performed using ReactomePA package (Yu and He, 2016) . It performs pathway analysis using the Reactome database implementing hypergeometric models. ReactomePA takes the input of genes as Ensemble IDs, therefore the gene symbols were converted to their corresponding Ensemble IDs using bitr function available in clusterProfiler package (Yu et al., 2012) . A q-value was set as the preferred < .

threshold for identifying significantly enriched pathways and their associated genes. GO term enrichment analysis of the significantly enriched pathway genes was performed using Mouse Genome Index (MGI) Mammalian Phenotype Level 4 gene set library available in Enrichr database (Kuleshov et al., 2016) . A p-value was set as the preferred threshold for < .

identifying significantly enriched terms and their associated genes.

The mouse miRNAs intended to target our hub genes were collected from StarBase v2.0 (Li et al., 2014) and miRWalk v3.0 (Sticht et al., 2018) databases, respectively. miRNAs with an overall score and binding on region were selected from miRWalk. Significant > . ′ TF-gene pairs with an integrated top rank score (p-value)

were fetched from ChEA < .

v3.0 database (Keenan et al., 2019) . miRNAs intended to target these extracted TFs were also collected from StarBase and miRWalk databases with previously described thresholds. The miRNAs targeting both our hub genes and TFs were considered as the final miRNAs. These miRNAs were now used to retrieve the lncRNA-miRNA and circRNA-miRNA interaction pairs from StarBase database. Lastly, all the five types of regulatory interaction pairs were integrated to establish the 5-node circRNA/lncRNA-miRNA-mRNA/TF regulatory network and visualized using Cytoscape.

In stage-I, a total of 284 Group-1, 802 Group-2, 55 Group-3, 206 Group-4, 99 Group-5, and 58 Group-6 DEGs were screened based on the p-value and threshold. 

The PPI network of screened DEGs constructed using STRING database comprised of 63 nodes and 157 edges as shown in figure 4(A). A total of 63 out of 256 stage-III DEGs participated in the PPI network at the selected highest confidence level, i.e. . Moreover, > .

the most highly significant cluster with a was selected amongst all the 5 = identified clusters and consisted of 11 nodes and 50 edges (figure 4B). Various topological /centrality distributions of the PPI network can be seen in figure 5(A-F).

The pathway enrichment analysis of these 11 genes revealed that only 4 genes (Isg15, Ddx58, Oasl1, Usp18) were involved in significantly enriched pathways and GO terms at the aforementioned threshold. The list of significantly enriched pathways and GO terms are shown in tables 1 and 2, respectively. Hence, these 4 genes were considered as the hub genes and used in further analysis. The boxplots comparing the daywise gene expression levels of these hub genes can be seen in figure 6 . GO analysis results have displayed that changes in biological processes of our hub genes were momentously implicated in abnormal circulating interferon levels, abnormal granulocyte morphology and physiology, increased activated T cell numbers, decreased bone strength, abnormal lymphocyte morphology and increased incidence of chronic myelocytic leukemia. In addition, our hub genes were involved in highly significant pathways such as antiviral mechanism by IFN-stimulated genes and interferon signaling.

The 5 

The 3-node miRNA FFL comprises 3 major regulatory interaction types (i.e., miRNA-mRNA repression; TF-mRNA regulation; miRNA-TF repression). It was composed of 26 nodes and 66 edges and is shown in figure 7(B) . The hub gene, Ddx58 is targeted by the maximum number of miRNAs (i.e., 9). Also, Stat1 and Mxd1 are the TFs targeted by the maximum number of miRNAs (i.e.,8). mmu-miR-34a-5p targeted maximum number of TFs (i.e.,4). The hub genes, Usp18 and Isg15 were regulated by a maximum number of TFs (i.e., 8). The highest-order subnetwork observed in the FFL included one miRNA (mmu-miR-124-3p), one TF (Stat2), one hub gene (Ddx58) and is shown in figure 7(C).

The 4-node circRNA/lncRNA-miRNA-mRNA ceRNA network comprised a total of 332 nodes and 578 edges as shown in figure 7(D) . The highest-order subnetwork observed included one miRNA (mmu-miR-124-3p), one hub gene (Ddx58), two circRNAs (Ppp1r10, C330019G07Rik), and one lncRNA (Gm26917) as shown in Figure 7 (E).

The analysis of FFL and ceRNA network revealed that one miRNA (mmu-miR-124-3p), one lncRNA (Gm26917), one TF (Stat2), one mRNA (Ddx58), and two circRNAs (Ppp1r10, C330019G07Rik) were the hub items in this quintuple regulatory network.

This study focuses on the identification of interactions between miRNAs, lncRNAs, circRNAs, TFs, and mRNAs to establish a regulatory network between them in case of SARS-CoV infection. This regulatory network will help us identify the probable targets and noncoding

RNAs which could directly act upon the genome and control the transcriptome on a large scale.

In order to analyze the modulations in host response to SARS-CoV, we started with the elucidation of mRNA expression of virus-infected mice at different time intervals. The mRNA expression data from a total of 21 samples at different time intervals was obtained from GEO dataset GSE19137. We compared the expression data in 5 different combinations and 3 stages.

Our analysis identified a total of 284 Group-1, 802 Group-2, 55 Group-3, 206 Group-4, 99

Group-5 and 58 Group-6 DEGs in stage-I, which were then vigorously screened for two more stages leading to the determination of overall 256 DEGs. Among them, 66% were upregulated and 34% were downregulated (Supplementary Table S1 ). Further, PPI network analysis indicated the presence of 5 prime clusters of induced genes, of which only 1 highly significant cluster with 11 nodes and 50 edges was identified (score=10) ( figure 4B ). Pathway enrichment analysis of genes present in this cluster divulged the significant involvement of only 4 genes in cogent pathways ( ). These genes (Isg15, Ddx58, Oasl1, Usp18) were -< .

described as the hub genes, all of which were considerably convoluted in antiviral mechanism by IFN-stimulated genes and Interferon signalling pathways (Table1).

We have observed a notable induction of well-delineated direct effectors of the innate immune system known as ISGs (IFN-stimulated genes), inclusive of Isg15, Usp18, Mx2, Oas3, Ifit3, along with several cytokines such as Cxcl3, Cxcl9, Cxcl10 and Il6. However, the genes involved in IFN-1 signalling (Ly6e, Mx1, Oas3, Ifi44l, If16, Ifitm3) and Type-III IFN related genes (Il28, Il29) were not robustly induced (Supplementary Table S1 ). These results are in Although IFN-I/III genes are expressed to a limited extent, they are sufficient enough to induce ISGs in infected cells. It has been well documented that IFN-III machinery is exclusively furnished for first defence against low doses of virus. However, when the viral dose exceeds, IFN-I comes into action, exaggerating the inflammatory process and generating disease immunopathology, thus indicating an important role of IFN-I, rather than IFN-III in triggering inflammation Galani et al., 2017; Kikkert, 2020) . Moreover, there exists a positive regulatory mechanism that augments IFN signalling cascade, thereby maintaining and amplifying ISGs. In this cascade, Stat1 and Irf9 (IFN regulatory factor), associates with Stat2 and forms Isgf3 transcription factor that binds to ISG promoter elements and amplifies the expression of ISGs. This enhanced and prolonged-expression of ISGs promotes viral resistance and locks the cells into an autocrine signalling loop that sustains IFN signal transduction and releases pro-inflammatory cytokines, which are responsible for the display of pathobiological features associated with the disease (Kikkert, 2020; Mesev et al., 2019) . Most of the patients develop atypical pneumonia specified by fever, fatigue, respiratory symptoms such as cough, sore throat, and shortness of breath. Acute diffuse alveolar damage (DAD), oedema, diffused fibrin, and hyaline membranes in the alveolar spaces, typical of ALI have been observed in early-stage of disease. However, in later stages, there is an organized phase DAD and eventual deposition of fibrous tissue with denuded airways, haemorrhage, and increased macrophage population (Gralinski and Baric, 2015) . Researchers have found that late-term progression of the disease is more likely to be associated with immunopathological damage, caused due to significant upregulation of pro-inflammatory cytokines such as IL-2, IL-7, IL-10, TNF-α, MCP-1 and G-CSF. This storm of cytokines are inducers of viral sepsis and inflammation-induced lung injury, leading to other complexities such as respiratory failure, shock, ARDS, organ failure and potentially death (Prompetchara et al., 2020) . Briefly, it has been found that viral infection reduces anti-viral IFN responses, as is also observed in our findings, leading to uncontrolled replication of virus and trigger of inflammatory conditions.

As a result, there is an intrusion of monocytes, macrophages and neutrophils that leads to enhanced production of pro-inflammatory cytokines, responsible for immunopathology of lung (Prompetchara et al., 2020) . Moreover, Usp18 also acts as a negative regulator of IFN signalling while competing with Jak1(Janus Kinase 1) for binding, after binding with the second chain of IFNα/β receptor 2 (Ifnar2). Thus, Usp18 has different effects on Isg15 conjugation and as well as altered IFN signalling, that needs to be interpreted very cautiously. Additionally, an unconjugated form of Isg15 functions as a cytokine stimulating IFN-γ production, NK cells proliferation, maturation of dendritic cells and acting as a chemotactic signal for neutrophils. It also stabilizes Usp18 and regulates IFN signalling by mediating autophagic degradation of viral sensors (RIG-I, also known as Ddx58, Retinoic acid-inducible gene1) (Choi et al., 2015; Perng and Lenschow, 2018, p. 15 ). During the course of a viral infection, RIG-I (i.e. pattern recognition receptor, encoded by DDX58 gene in humans) senses viral RNPs leading to its oligomerization and association with mitochondrial antiviral signalling protein (MAVs), with subsequent activation and induction of ISGs (Perng and Lenschow, 2018, p. 15 ). In addition, it has also been reported that SARS-CoV-2 spike protein (S), binds with angiotensin-converting enzyme 2(ACE2) and

stimulates viral entry into the host, following association with host proteases, mainly transmembrane serine protease2 (TMPRSS2). Both ACE2 and TMPRSS2 are expressed on nasal secretory cells, type II pneumocytes and absorptive enterocytes. ACE2 is upregulated by Type-I IFNs and Type-II IFNs to a lesser extent (Ziegler et al., 2020) . Thus, it could also be an ISG possessing antiviral effect promoting viral egress. Studies have reported that binding of SARS-CoV to mouse ACE2, reduces its expression and causes lung failure. However, it is very weakly induced in case of murine cells. This can also be related to our results where there is no notable induction of IFNs, ACE2 and TMPRSS2. Further, the S protein of human SARS-CoV has a very high binding affinity for human ACE2 than that of mice and rats (Li et al., 2004; Tseng et al., 2007) . Thus, restrictions posed by host factors also play an important part in selection of genes to study the dynamics of host pathogen interactions in SARS-CoV-2 infection. Moreover, targeting ISGs and strategies to fine tune their levels of expression would be beneficial in developing an effective therapeutic tool against the virus.

In this respect, other parts of the innate immune system package such as small noncoding (micro, circular) and long noncoding RNAs are considered. These elements are of considerable importance as they have been implicated in the regulation of numerous pathological and physiological processes in animals and humans. It has been found that several host miRNAs are deregulated in order to confound the immune system against a viral infection. In addition, lncRNAs also play powerful roles in inflammatory pathways, thereby regulating gene expression through multiple mechanisms including ceRNA theory. As conceded in this theory, lncRNAs act as "miRNA sponges" and reduce the degradative effects of miRNAs on their target mRNAs (Ghosal et al., 2014) . Based on this, our study has identified a quintuple network, consisting of one miRNA (miR-124-3p), one lncRNA (Gm26917), one TF (Stat2), one mRNA (Ddx58) and two circRNAs (Ppp1r10, C330019G07Rik). miR-124-3p is known to modulate TLR-mediated innate immune responses by targeting Stat3 and reduce the secretion of Il6 and TNF-α (Qin et al., 2016) . It has been found to be upregulated in case of HIV-1 infection, causing downregulation of p21 and TASK1, consequently leading to an increase in the release of virions (Farberov et al., 2015) .

Viruses have their own ways to promote their replication. One way is to hijack the host RNA helicases (Kikkert, 2020) . RIG-I/Ddx58 receptors have a helicase domain which interacts with viral nsp13 and initiates the viral life cycle. Ddx58 is highly upregulated (as observed in our analysis), in SARS-CoV-2 infected cells, which could also be one of the probable reason for increase in viral replication. Ddx58 is also involved in processes of mRNA splicing and miRNA biogenesis and thus, its upregulation would cause reprogramming of miRNA splicing events resulting in downregulation of miRNAs such as miR-124-3p which has its predicted site in 3'-UTR of Ddx58 (Cheng et al., 2018; Dardenne et al., 2014) . Thus, overexpression of miR-124-3p would cause the degradation of Ddx58, thereby resulting in the reduction of viral replication. Moreover, RIG-I/Ddx58 also augments Stat1 (TF), which upon phosphorylation combines with Stat2 and IFN regulatory factor 9 (Ifn9) to form heterotrimers and initiate the transcription of ISGs to exert antiviral effects (Jiang et al., 2011) . Moreover, to evade ISG mediated antiviral effects, the virus may also induce cytosolic translocation of Drosha (an enzyme involved in miRNA biogenesis) (Shapiro et al., 2014) , which could reprogram the splicing events to yield another lncRNAs and circRNAs that could sponge miR-124-3p and hamper its degradative actions on Ddx58.

Overall, it can be speculated that despite of non-significant induction of IFNs and hence absence of considerable upregulation of ACE2 and TMPRSS2 in mice, the viruses still gain entry into the cell. Although the secreted IFNs are very limited in amount but are sufficient enough to weakly induce ACE2 that promotes binding of virus to the host cell. Later on, SARS-CoV-2 identifies the target cells and utilises the host system to promote their replication. This process begins with an increase in expression of ISGs, as a part of host innate immune response, but the virus modulates the system in its own way to capture the IFN releasing mechanisms and reduce the secretion of IFNs. Although IFNs are secreted in very low amounts, but are sufficient enough to induce ISGs, along with viral sensor RIG-I/Ddx58. Since ACE2 is also IFN induced, it can also be considered as an ISG. ISGs generally have antiviral effects but some such as Isg15 also possess proviral effects. Increased Isg15 may result in the generation of an autocrine loop that could amplify and prolong their own secretion, ultimately leading to the development of viral resistance. Further, the virus also confiscates host RNA helicases such as the helicase domain in Ddx58 to enhance viral replication independent of IFN related pathways. However, Ddx58 is also implicated in splicing events of miRNA biogenesis, thus association of viral helicase with Ddx58 may alter these splicing events in order to provide replication advantage to viruses. Drosha is another enzyme involved in miRNA biogenesis and it would also be steered by viruses to reprogram splicing events associated with miRNA biogenesis to synthesize other noncoding RNAs that could sponge the degradative effect of miR-124-3p on Ddx58 and hence favour viral replication.

Although the study is carried out on mRNA expression data of SARS-CoV (Human SARS-CoV TOR2, SARS-related human coronavirus (NC_004718)) infected mice (Lau et al., 2015) .

This strain belongs to the genus Betacoronaviruses and phylogenetic analysis have shown that all bat derived coronaviruses (causative of , fall under all five subgenera of the Genus Betacoronaviruses and share 99% of genomic similarities (Lu et al., 2020) . Thus, it can be speculated that SARS-COV-2 also utilizes the similar strategies to modulate host immune responses, such as dampening of IFN-I response, but additional mechanisms need to be uncovered. Moreover, the deregulation of IFN-I/III regulated genes has been observed in SARS-CoV infection, leading to uncontrolled viral replication and other immunopathologic conditions. Since these genes are also found to be deregulated in studies associated with SARS-CoV-2 infection (Blanco-Melo et al., 2020) , it is assumed to have similar effects in SARS-CoV-2 infection. Thus, we could see from the above network that IFNs play a pivotal role in antiviral responses and strategies to carefully balance the levels of IFNs are essentially required to maintain an equilibrium between tissue tolerance and viral infection. Furthermore, this network could be a very effective tool in understanding the dynamics of host and virus interactions taking place in a SARS-CoV-2 infected cell.

The key limitations of our study is that it is based on the data available on public databases, however, it needs further in vitro and in vivo validation to determine its clinical efficiency.

Additionally, the study highlights the prospective interactions between mRNAs, miRNA and ceRNAs based on database search, but does not include the expression data of miRNA, lncRNA and circRNA. Availability of this data would enhance the visionary attributes of interactions and would be more beneficial in establishing a clear understanding of the mechanisms involved.

The present study identifies a quintuple ceRNA network involving miRNA (miR-124-3p), lncRNA (Gm26917), circRNAs (Ppp1r10, C330019G07Rik), mRNA (Ddx58) and a TF DEGs, were uniquely compared with each other in order to obtain 316 stage-II DEGs. 

 Bioinformatics analysis of mouse mRNA expression dataset for presumptive SARS-CoV-2 targets.  Induction of ISGs-Isg15, Oasl1, Usp18 and Ddx58 with no marked changes in the expression of IFNs  No induction of ACE2 and TMPRSS2, raising implications for host factor limitations.

 Identification of ceRNA network including miR-124-3p, Ddx58, lncRNA (Gm26917) and circRNAs (Ppp1r10, C330019G07RiK).  Virus regulates the expression of lnc and circRNAs, acting as sponges for miR-124-3p targeting Ddx58. 

Transcriptome Meta-Analysis Deciphers a Dysregulation in Immune Response-Associated Gene Signatures during Sepsis

Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract

MicroRNA Involvement in Signaling Pathways During Viral Infection. Front

SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems (preprint)

Features, Evaluation and Treatment Coronavirus (COVID-19), in: StatPearls. StatPearls Publishing

DDX5 RNA Helicases: Emerging Roles in Viral Infection

Oligoadenylate synthaselike (OASL) proteins: dual functions and associations with diseases

The Gene Expression Omnibus Database

2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members

RNA helicases DDX5 and DDX17 dynamically orchestrate transcription, miRNA, and splicing programs in cell differentiation

MicroRNA-mediated regulation of p21 and TASK1 cellular restriction factors enhances HIV-1 infection

SARS coronavirus and innate immunity

Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness

HumanViCe: host ceRNA network in virus infected cells in human

Molecular pathology of emerging coronavirus infections

Pathology and pathogenesis of severe acute respiratory syndrome

COVID-19: progression of disease and intravascular coagulation -present status and future perspectives

A Computational Approach for Predicting Role of Human MicroRNAs in MERS-CoV Genome

Gene regulation by transcription factors and microRNAs

Susceptibility to SARS coronavirus S proteindriven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor

RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation

ChEA3: transcription factor enrichment analysis by orthogonal omics integration

Innate Immune Evasion by Human Respiratory RNA Viruses

Enrichr: a comprehensive gene set enrichment analysis web server 2016 update

Coronavirus ORF8 Protein Is Acquired from SARS-Related Coronavirus from Greater Horseshoe Bats through Recombination

Transcription of eukaryotic protein-coding genes

starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data

Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Pathogenesis of COVID-19 from a cell biology perspective

Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-omethyltransferase activity

Decoding type I and III interferon signalling during viral infection

A novel lncRNA-miRNA-mRNA triple network identifies lncRNA TWF1 as an important regulator of miRNA and gene expression in coronary artery disease

Identification of potential crucial genes and construction of microRNA-mRNA negative regulatory networks in osteosarcoma

ISG15 in antiviral immunity and beyond

Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac

Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus

miRNA-124 in Immune System and Immune Disorders

A diverse range of gene products are effectors of the type I interferon antiviral response

Global and local architecture of the mammalian microRNA-transcription factor regulatory network

Cytoscape: a software environment for integrated models of biomolecular interaction networks

Drosha as an interferon-independent antiviral factor

Identification of differentially expressed genes in small and non-small cell lung cancer based on meta-analysis of mRNA

Network-based identification of signature genes KLF6 and SPOCK1 associated with oral submucous fibrosis

miRWalk: An online resource for prediction of microRNA binding sites

Uncovering MicroRNA and Transcription Factor Mediated Regulatory Networks in Glioblastoma

STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets

SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon

MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals

Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Alternative Progenitor Lineages Regenerate the Adult Lung Depleted of Alveolar Epithelial Type 2 Cells

ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization

clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

Transcription factor and microRNA co-regulatory loops: important regulatory motifs in biological processes and diseases

HCA Lung Biological Network. Electronic address: lung-network@humancellatlas.org, HCA Lung Biological Network, 2020. SARS-CoV-2 Receptor ACE2 Is an Interferon

We would like to thank Jamia Millia Islamia for providing infrastructure, journal access, 

The authors declare no competing interests.

The present study was supported by the Science and Engineering Research Board (SERB),